Noteworthy, only 1.8% of TP53/RB1 mutated SCLC were HPV+ compared to 12.7% of TP53 and/or RB1 WT cases, thus reinforcing a possible correlation between SCLC and HPV infection. This evidence concerns the gene TP53 and small cell lung carcinoma.